22.01.2018 21:53:00

SHAREHOLDER ALERT: Monteverde & Associates PC Launches An Investigation of the Board of Directors and Officers of BioCryst Pharmaceuticals, Inc. - BCRX

NEW YORK, Jan. 22, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors and Officers of BioCryst Pharmaceuticals, Inc. ("BioCryst" or the "Company") (NasdaqGS: BCRX) for possible breaches of fiduciary duty.

Monteverde & Associates PC Logo

Click here for more information: http://monteverdelaw.com/investigations/m-a/.  It is free andthere is no cost or obligation to you.

Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders and consumers from corporate wrongdoing.  Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013 and 2017, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017 Top Rated Lawyer.

If you own common stock in BioCryst and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2018 Monteverde & Associates PC.  The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde--associates-pc-launches-an-investigation-of-the-board-of-directors-and-officers-of-biocryst-pharmaceuticals-inc--bcrx-300586190.html

SOURCE Monteverde & Associates PC

Analysen zu BioCryst Pharmaceuticalsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

BioCryst Pharmaceuticals 7,32 3,86% BioCryst Pharmaceuticals